Long non-coding RNA expression profile in human gastric cancer and its clinical significances

Table 2 The relationship of H19 and uc001lsz expression levels (Δ C _t ) in cancer tissues with clinicopathological factors of patients with gastric cancer ^a

Characteristics	No. of patients (%)	H19		uc001lsz
Characteristics		Mean ± SD	P value	Mean ± SD	P value
Age (y)
≥ 60	59 (76.6)	8.74 ± 4.67	0.588	18.85 ± 4.94	0.240
< 60	18 (23.4)	8.08 ± 3.99		17.28 ± 4.85
Gender
Male	57 (74.0)	8.66 ± 4.81	0.823	18.19 ± 5.01	0.355
Female	20 (26.0)	8.40 ± 3.44		19.37 ± 4.58
Diameter (cm)^b
≥ 5	39 (52.0)	7.98 ± 4.44	0.282	18.49 ± 5.03	0.682
< 5	36 (48.0)	9.10 ± 4.53		18.01 ± 5.11
CEA^b
Positive	48 (64.0)	8.45 ± 4.21	0.882	18.28 ± 4.54	0.593
Negative	27 (36.0)	8.61 ± 5.01		18.92 ± 5.71
CA19-9^b
Positive	40 (53.3)	8.68 ± 3.87	0.720	18.65 ± 4.64	0.792
Negative	35 (46.7)	8.31 ± 5.14		18.35 ± 5.37
Differentiation^c
Well	3 (4.9)	8.28 ± 1.92	0.635	15.34 ± 5.40	0.371
Moderate	33 (54.1)	9.05 ± 4.40		19.37 ± 4.85
Poor	25 (41.0)	7.84 ± 5.47		19.54 ± 4.91
Lymphatic metastasis^c
N0	20 (32.8)	8.95 ± 3.17	0.926	18.55 ± 6.01	0.472
N1&N2&N3	41 (67.2)	9.07 ± 5.25		19.53 ± 4.39
Distal metastasis^c
M0	58 (95.1)	8.87 ± 4.70	0.258	19.13 ± 5.02	0.617
M1	3 (4.9)	12.00 ± 1.30		20.62 ± 3.74
Invasion^c
Tis&T1-T3	20 (32.8)	10.04 ± 3.86	0.237	17.73 ± 4.72	0.105
T4	41 (67.2)	8.53 ± 4.95		19.93 ± 4.95
TNM stage^c
0&I&II	24 (39.3)	9.40 ± 3.86	0.620	17.81 ± 5.52	0.032
III&IV	37 (60.7)	8.79 ± 5.14		20.49 ± 3.98

^aAll samples are consist of 16 endoscopic biopsy samples and 61 surgery samples from patients with gastric cancer.
^bNot detected for 2 patients who were performed endoscopy examination.
^cOnly includes 61 surgery patients.

ISSN: 1479-5876